Tenet Healthcare Co. (NYSE:THC – Get Free Report) Director Richard W. Fisher sold 2,500 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $123.20, for a total value of $308,000.00. Following the sale, the director now directly owns 17,627 shares in the company, valued at $2,171,646.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Tenet Healthcare Stock Up 3.9 %
Shares of NYSE:THC traded up $4.84 on Thursday, reaching $127.68. The company had a trading volume of 1,181,828 shares, compared to its average volume of 1,215,883. The company has a current ratio of 1.44, a quick ratio of 1.37 and a debt-to-equity ratio of 2.58. The firm has a market capitalization of $12.47 billion, a PE ratio of 4.77, a PEG ratio of 1.22 and a beta of 2.09. Tenet Healthcare Co. has a 52-week low of $51.04 and a 52-week high of $127.73. The firm’s 50 day simple moving average is $102.33 and its 200-day simple moving average is $84.00.
Tenet Healthcare (NYSE:THC – Get Free Report) last released its quarterly earnings results on Tuesday, April 30th. The company reported $3.22 EPS for the quarter, beating the consensus estimate of $1.45 by $1.77. The business had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.15 billion. Tenet Healthcare had a net margin of 12.53% and a return on equity of 26.76%. The company’s quarterly revenue was up 6.9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.42 earnings per share. As a group, analysts expect that Tenet Healthcare Co. will post 8.73 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Tenet Healthcare
Wall Street Analyst Weigh In
Several research firms have recently weighed in on THC. TheStreet upgraded Tenet Healthcare from a “c+” rating to a “b-” rating in a report on Tuesday, February 6th. Stephens lifted their price target on shares of Tenet Healthcare from $95.00 to $122.00 and gave the stock an “equal weight” rating in a research note on Wednesday, May 1st. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Tenet Healthcare from $100.00 to $126.00 and gave the stock a “buy” rating in a research report on Friday, April 12th. Truist Financial reaffirmed a “buy” rating and set a $130.00 target price (up previously from $120.00) on shares of Tenet Healthcare in a research note on Wednesday, May 1st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $104.00 price objective on shares of Tenet Healthcare in a research report on Wednesday, April 10th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Tenet Healthcare presently has an average rating of “Buy” and a consensus price target of $113.19.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Stories
- Five stocks we like better than Tenet Healthcare
- What is a SEC Filing?
- Roblox: The Bottom Just Fell Out of the Metaverse
- What are earnings reports?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- What is Put Option Volume?
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.